Identification of anti-HBV activities in Paeonia suffruticosa Andr. using GRP78 as a drug target on Herbochip®

[1]  C. Silvestri,et al.  The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine. , 2016, Journal of infection and public health.

[2]  O. Yokosuka,et al.  Current and future directions for treating hepatitis B virus infection. , 2015, World journal of hepatology.

[3]  Lemonica Koumbi.  Current and future antiviral drug therapies of hepatitis B chronic infection. , 2015, World journal of hepatology.

[4]  M. D. Chang,et al.  Identification of anti-inflammatory fractions of Geranium wilfordii using tumor necrosis factor-alpha as a drug target on Herbochip® – an array-based high throughput screening platform , 2015, BMC Complementary and Alternative Medicine.

[5]  J. Bussink,et al.  The unfolded protein response as a target for cancer therapy. , 2014, Biochimica et biophysica acta.

[6]  Ji-liang He,et al.  Chinese herbal medicine for carriers of the hepatitis B virus: an updated systematic review and meta-analysis. , 2014, Pharmazie.

[7]  Zongwei Li,et al.  Reconstructed mung bean trypsin inhibitor targeting cell surface GRP78 induces apoptosis and inhibits tumor growth in colorectal cancer. , 2014, The international journal of biochemistry & cell biology.

[8]  Xiao-Bin Jia,et al.  The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats. , 2014, Journal of ethnopharmacology.

[9]  Lin Zhao,et al.  Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection. , 2013, Drug discoveries & therapeutics.

[10]  Mei-Yi Lin,et al.  Cortex Moutan Induces Bladder Cancer Cell Death via Apoptosis and Retards Tumor Growth in Mouse Bladders , 2013, Evidence-based complementary and alternative medicine : eCAM.

[11]  Yachao Li,et al.  CD147 induces UPR to inhibit apoptosis and chemosensitivity by increasing the transcription of Bip in hepatocellular carcinoma , 2012, Cell Death and Differentiation.

[12]  Ji Hye Kim,et al.  Ethanol extract of paeonia suffruticosa Andrews (PSE) induced AGS human gastric cancer cell apoptosis via fas-dependent apoptosis and MDM2-p53 pathways , 2012, Journal of Biomedical Science.

[13]  L. Roberts,et al.  The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. , 2011, Seminars in cancer biology.

[14]  Junji Furuse,et al.  The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. , 2010, The oncologist.

[15]  Y. Lai,et al.  The Anti-hepatitis B Virus Activity of Boehmeria nivea Extract in HBV-viremia SCID Mice , 2008, Evidence-based complementary and alternative medicine : eCAM.

[16]  J. Sung,et al.  Glucose-regulated Protein 78 Is an Intracellular Antiviral Factor against Hepatitis B Virus , 2009, Molecular & Cellular Proteomics.

[17]  Y. Lai,et al.  Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells , 2009, Journal of viral hepatitis.

[18]  Z. Gu,et al.  Screening of Bioactive Compounds from Moutan Cortex and Their Anti-Inflammatory Activities in Rat Synoviocytes , 2007, Evidence-based complementary and alternative medicine : eCAM.

[19]  D. Lau,et al.  Review: Current status of antiviral therapy for hepatitis B , 2008, Therapeutic advances in gastroenterology.

[20]  M. D. Chang,et al.  GRP78 and Raf‐1 cooperatively confer resistance to endoplasmic reticulum stress‐induced apoptosis , 2008, Journal of cellular physiology.

[21]  A. Alisi,et al.  Viral hepatitis B: established and emerging therapies. , 2008, Current medicinal chemistry.

[22]  K. Fung,et al.  Pharmacological investigations of the anti-diabetic effect of Cortex Moutan and its active component paeonol. , 2007, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[23]  H. Kung,et al.  Screening of active ingredients of herbal medicine for interaction with CYP450 3A4 , 2007, Phytotherapy research : PTR.

[24]  A. Cheng,et al.  Antiviral effects of PNA in duck hepatitis B virus infection model , 2007, Acta Pharmacologica Sinica.

[25]  Y. Lai,et al.  Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells. , 2006, World journal of gastroenterology.

[26]  I. Su,et al.  Hepatitis B virus pre‐S mutants, endoplasmic reticulum stress and hepatocarcinogenesis , 2006, Cancer science.

[27]  W. Lau,et al.  A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma. , 2005, Journal of the National Cancer Institute.

[28]  Hollins P. Clark,et al.  Staging and current treatment of hepatocellular carcinoma. , 2005, Radiographics : a review publication of the Radiological Society of North America, Inc.

[29]  Seung-Oe Lim,et al.  Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. , 2005, World journal of gastroenterology.

[30]  SeungOeLim,et al.  Expression of heat shock proteins （HSP27, HSP60, HSP70, HSP90,GRP78, GRP94） in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules , 2005 .

[31]  P. Marion,et al.  Entecavir Therapy Combined with DNA Vaccination for Persistent Duck Hepatitis B Virus Infection , 2003, Antimicrobial Agents and Chemotherapy.

[32]  M. Berg,et al.  Isolation, expression, and characterization of fully functional nontoxic BiP/GRP78 mutants. , 2001, Protein expression and purification.

[33]  T. Yen,et al.  Activation of hepatitis B virus S promoter by the viral large surface protein via induction of stress in the endoplasmic reticulum , 1997, Journal of virology.